Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimodipine for Vascular Depression
NCT00781326Phase 4Terminated
- Sponsor
- University of Pittsburgh
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in major depressive disorder (MDD) comparing Nimodipine Arm with Placebo Arm (2 arms). Primary endpoint: Hamilton Depression Rating Scale (24 Item) at 24 weeks. Started Aug 2008; status: terminated.
02
Drugs
nimodipine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00781326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00781326.